v3.25.4
Stockholders' Equity - Schedule of Restricted Stock and Contingent Restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2025
Number of Restricted Shares      
Granted (in shares) 400,000 500,000  
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 4.36 $ 3.9  
Restricted Stock      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 670,285    
Vested (in shares) (190,569)    
Unvested, end of period (in shares) 880,848   670,285
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 5.58    
Vested (in USD per share) 6.3    
Unvested, end of period (in USD per share) $ 4.97   $ 5.58
Unamortized compensation expense $ 2,982   $ 2,196
Weighted Average Remaining Amortization Period (Years) 1 year 8 months 12 days   1 year 7 months 6 days
Restricted Stocks Time Vested      
Number of Restricted Shares      
Granted (in shares) 214,423    
Unvested, end of period (in shares) 371,997    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 4.75    
Unvested, end of period (in USD per share) $ 5.4    
Restricted Stocks Time Vested | Employee      
Number of Restricted Shares      
Granted (in shares) 200,000 200,000  
Restricted Stock, Performance Based | Employee      
Number of Restricted Shares      
Granted (in shares) 200,000 200,000  
Contingent Restricted Stock Grants      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 241,613    
Unvested, end of period (in shares) 241,613   241,613
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 2.37    
Unvested, end of period (in USD per share) $ 2.37   $ 2.37
Unamortized compensation expense $ 236   $ 340
Weighted Average Remaining Amortization Period (Years) 1 year 3 months 18 days   1 year 9 months 18 days
Restricted Stock And Contingent Restricted Stock | Employee      
Number of Restricted Shares      
Granted (in shares)   100,000  
Performance Based Contingent Shares      
Number of Restricted Shares      
Granted (in shares) 186,709    
Unvested, end of period (in shares) 508,851    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 4.36    
Unvested, end of period (in USD per share) $ 4.65